top of page

FOUNDING TEAM

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque leo mauris, pretium et ipsum quis, convallis ullamcorper sem. Maecenas elementum nibh nisi, eu auctor nunc pulvinar vitae. Donec ut interdum leo. Nam ac felis semper, facilisis nulla venenatis, molestie nibh.

FOUNDING TEAM

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque leo mauris, pretium et ipsum quis, convallis ullamcorper sem. Maecenas elementum nibh nisi, eu auctor nunc pulvinar vitae. Donec ut interdum leo. Nam ac felis semper, facilisis nulla venenatis, molestie nibh.

FOUNDING TEAM

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque leo mauris, pretium et ipsum quis, convallis ullamcorper sem. Maecenas elementum nibh nisi, eu auctor nunc pulvinar vitae. Donec ut interdum leo. Nam ac felis semper, facilisis nulla venenatis, molestie nibh.

FOUNDING TEAM

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque leo mauris, pretium et ipsum quis, convallis ullamcorper sem. Maecenas elementum nibh nisi, eu auctor nunc pulvinar vitae. Donec ut interdum leo. Nam ac felis semper, facilisis nulla venenatis, molestie nibh.

PD Dr. Andrea Chicca

Project leader/senior scientist at UniBern.

2 years in pharma industry.

8 years of research activity on the ECS

Prof. Dr. Jürg Gertsch

Full Professor at UniBern.
Collaboration with pharma industry.
10+ years of research activity on the ECS.

May 2018 // Science

Updated: Nov 6, 2020

Publication of a scientific article describing the pharmacology of WOBE437 (first generation SERI) in a mouse model of pain and chronic inflammation. Reynoso-Moreno I et al., Front Mol Neurosci. 2018 May 28;11:180. Full text: https://www.frontiersin.org/articles/10.3389/fnmol.2018.00180/full

Recent Posts

July 2023 // Communication

Synendos Therapeutics AG announces that co-founder and Scientific Advisor Board member, Professor Jürg Gertsch, presented groundbreaking...

June 2022 // Communication

In a last newsletter edition from NCCR Transcure, we can look behind the scenes of our technology transfer success story.

March 2021 // Science

We are excited to share a scientific publication about the beneficial effect of the prototype SERI WOBE437 in a clinically relevant mouse...

bottom of page